Drug delivery Archives

News and Trends 11 Jun 2020

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

British biotech Evox Therapeutics has signed a collaboration deal worth up to €1.1B with US big pharma Eli Lilly to develop RNA drugs that are delivered in exosomes to the brain to treat neurological diseases. As part of the deal, Evox will get €17.6M upfront to fund research for the next three years and Lilly […]

June 11, 2020 - 3 minutesmins - By Helen Albert

Startup Scout 14 Jun 2019

This Biotech Reduces Drug Side Effects Using Silica Gel Implants

DelSiTech is a Finnish company developing injectable silica gel implants that release drugs slowly over time, causing fewer side effects and helping patients stick to their treatment regimen. Mission: To develop silica gels that slowly release drugs over time to treat conditions including HIV, hepatitis B, retinal disease and cancer. One big problem in chronic […]

June 14, 2019 - 3 minutesmins - By Jonathan Smith

Infographics 28 Nov 2018

Infographic: The Next Big Thing in Biological Drug Delivery

By the year 2022, half of the top 100 drug sales will be biologics. And with 2,700 biologics currently in development, the market will soon be booming. But there is a hitch: Most biological drugs are administered parenterally. And though this is better than nothing, it does coincide with high treatment costs and stress for […]

November 28, 2018 - 1 minutemin - By External Contributor

News and Trends 3 Sep 2018

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Evox Therapeutics has raised £35.5M (€39.4M) in a Series B fundraising that has been backed, among others, by the venture arm of Google’s parent company. A spin-out from the University of Oxford and the Karolinska Institute, Evox Therapeutics has raised a large round that will fund the development of its drug delivery technology to […]

September 3, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Feb 2018

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a GLP-1 based treatment for type II diabetes. This could be the first oral GLP-1 treatment on the market, making it easier for patients to take the drug. After obtaining approval for an injected version, Novo Nordisk is now getting ready […]

February 23, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 19 Dec 2017

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

Santa Claus is not the only busy one in the weeks leading up to Christmas this year, with Boehringer Ingelheim signing collaborations with Autifony and Evox Therapeutics. In the last couple of days, Boehringer Ingelheim has agreed to collaborate with two exciting British biotechs. On Monday, a deal worth up to €627.5M was agreed with CNS disorders specialist, […]

December 19, 2017 - 2 minutesmins - By Alex Dale

News and Trends 10 Oct 2016

Meet the French CEO who wants to Break Barriers to Drug Delivery

The objective of the French biotechnology company, Vect-Horus, is to leverage its technology, VECTrans, to facilitate the delivery of drugs into the brain and other organs. For this innovation, the company recently received the Frost & Sullivan 2016 Leadership award, which independently recognizes companies for demonstrating excellence in developing innovative technologies and practices within an industry. […]

October 10, 2016 - 5 minutesmins - By Marie Godar

roche cellsqueeze sqz cell therapies Cancer

News and Trends 9 Dec 2015

Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?

The MIT spin-off SQZ Biotech has an invention (Cell SQueeZe) which could make vector drug delivery in Cancer a thing of the past… Roche thinks so too, and has now acquired this small biotech for €455M upfront. MIT Professors Klavs Jensen, Robert Langer and PhD Student Armon Sharei were focused on developing a more effective system for […]

December 9, 2015 - 3 minutesmins - By Dani Bancroft

nanomedicine cubosomes nestle epfl cime coimbra

News and Trends 18 Nov 2015

Nanomedicine Inside Out: A Nestlé Advance in Cuboid Drug Delivery Systems

A New feat in Nanomedicine: The Cubosome drug delivery system has now been 3D-mappped and studied internally by Scientists from the Swiss Federal Institute of Technology (EPFL) and University of Coimbra (Portugal) at the Nestlé Research Center in Lausanne (Switzerland). What are Cubosomes? These small nanostructures are ‘crystalline liquid phases’ engineered in bulk to hold […]

November 18, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 7 Jul 2015

Novo Nordisk abandons Zosano’s drug delivery technology for diabetes treatment

Novo Nordisk cancels its collaboration deal with Zosano Pharma. The diabetes drug semaglutine won’t be delivered with the microneedle patch technology, developed from the latter. Zosano’s patch technology uses thin titanium microprojections to deliver drugs that cannot permeate the outer layer of the skin. According to Zosano, the system was tested on 400 patients in […]

July 7, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Feb 2015

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Ferring Pharmaceuticals signed an agreement with South Korean CTCBIO to acquire rights to a novel oral drug delivery technology. The Swiss company is growing more and more rapidly with plenty of updates since the begining of the year. Ferring’s success in developing oral formulations for peptide drugs including the world’s first orally active peptide, desmopressin […]

February 26, 2015 - 2 minutesmins - By Lourdes Riquelme

Intarcia Platform Technology deal Servier

News and Trends 15 Nov 2014

Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?

The French company Servier wants to invest one billion euros by a partnering with the American company Intarcia regarding their subcutaneous implant for diabetes. This is a breakthrough micropump, the first device without injection able to deliver the molecule Exenatide during one year. It is a huge step forward in treating type 2 diabetes. Indeed, most people forget […]

November 15, 2014 - 2 minutesmins - By Julie Lellouche

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Drug delivery

Evox and Lilly Partner to Develop Neuro RNA Drugs in Deal Worth €1.1B

This Biotech Reduces Drug Side Effects Using Silica Gel Implants

Infographic: The Next Big Thing in Biological Drug Delivery

Oxford Biotech Raises €40M to Deliver Drugs to Hard-to-Reach Targets

Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes

Schizophrenia and Drug Delivery Biotechs Sign a Major Pharma Partner

Meet the French CEO who wants to Break Barriers to Drug Delivery

Squeezing Cells: A Revolutionary Cancer Drug Delivery Platform for €455M?

Nanomedicine Inside Out: A Nestlé Advance in Cuboid Drug Delivery Systems

Novo Nordisk abandons Zosano’s drug delivery technology for diabetes treatment

Unstoppable Ferring after the Acquisition of a novel Oral Drug Delivery Technology

Why do Servier bets one Billion euros on Revolutionary Diabetes Drugs Delivery Device?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!